NovaBay Pharmaceuticals Soars 66% In Pre-Market On $6 Million Investment Deal, CEO Appointment - NovaBay Pharmaceuticals (AMEX:NBY)

NovaBay Pharmaceuticals Soars 66% In Pre-Market On $6 Million Investment Deal, CEO Appointment - NovaBay Pharmaceuticals (AMEX:NBY)

NovaBay Pharmaceuticals Inc. (NYSE:NBY) surged 66.57% in pre-market trading to $1 on Wednesday, following the announcement of major investment and leadership changes that could prevent the company’s liquidation. Check out how NBY stock is trading here. $6 Million Investment Saves Company From Dissolution The California-based biopharmaceutical company announced on Monday, it secured a $6 million securities purchase agreement with private investor…

NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor ...

EMERYVILLE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a $6 million securities purchase agreement with private investor David E. Lazar for the purchase of the…